GILEAD SCIENCES, INC. Increase (Decrease) in Income Taxes Payable
GILEAD SCIENCES, INC. (GILD) reported Increase (Decrease) in Income Taxes Payable of -$568.00 million for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedIncomeTaxesPayable · last filed 2023-02-22
- GILEAD SCIENCES, INC. increase (decrease) in income taxes payable for the quarter ending 2022-12-31 was -$4.00M, a 104.04% decline year-over-year.
- GILEAD SCIENCES, INC. increase (decrease) in income taxes payable for the quarter ending 2022-09-30 was $78.00M, a 8.33% increase year-over-year.
- GILEAD SCIENCES, INC. increase (decrease) in income taxes payable for the quarter ending 2022-06-30 was -$496.00M.
- GILEAD SCIENCES, INC. increase (decrease) in income taxes payable for the quarter ending 2022-03-31 was -$146.00M.
- GILEAD SCIENCES, INC. increase (decrease) in income taxes payable for fiscal 2022 was -$568.00M.
- GILEAD SCIENCES, INC. increase (decrease) in income taxes payable for fiscal 2021 was -$364.00M.
- GILEAD SCIENCES, INC. increase (decrease) in income taxes payable for fiscal 2020 was -$778.00M, a 386.03% decline from fiscal 2019.
- GILEAD SCIENCES, INC. increase (decrease) in income taxes payable for fiscal 2019 was $272.00M.
| Period end | Increase (Decrease) in Income Taxes Payable 3 month | Increase (Decrease) in Income Taxes Payable 3 month as first filed | Increase (Decrease) in Income Taxes Payable 6 month | Increase (Decrease) in Income Taxes Payable 6 month as first filed | Increase (Decrease) in Income Taxes Payable 9 month | Increase (Decrease) in Income Taxes Payable 9 month as first filed | Increase (Decrease) in Income Taxes Payable 12 month | Increase (Decrease) in Income Taxes Payable 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-12-31 | -$4.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $74.00M derived: sum of 2 quarters · filed 2023-02-22 | -$422.00M derived: sum of 3 quarters · filed 2023-02-22 | -$568.00M 10-K · filed 2023-02-22 | ||||
| 2022-09-30 | $78.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$418.00M derived: sum of 2 quarters · filed 2022-11-02 | -$564.00M 10-Q · filed 2022-11-02 | -$465.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2022-06-30 | -$496.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$642.00M 10-Q · filed 2022-08-08 | -$543.00M derived: sum of 3 quarters · filed 2023-02-22 | -$471.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2022-03-31 | -$146.00M 10-Q · filed 2022-05-04 | -$47.00M derived: sum of 2 quarters · filed 2023-02-22 | $25.00M derived: sum of 3 quarters · filed 2023-02-22 | -$194.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-12-31 | $99.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $171.00M derived: sum of 2 quarters · filed 2023-02-22 | -$48.00M derived: sum of 3 quarters · filed 2023-02-22 | -$364.00M 10-K · filed 2023-02-22 | ||||
| 2021-09-30 | $72.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$147.00M derived: sum of 2 quarters · filed 2022-11-02 | -$463.00M 10-Q · filed 2022-11-02 | -$813.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-06-30 | -$219.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | -$535.00M 10-Q · filed 2022-08-08 | -$885.00M derived: sum of 3 quarters · filed 2023-02-22 | -$952.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2021-03-31 | -$316.00M 10-Q · filed 2022-05-04 | -$666.00M derived: sum of 2 quarters · filed 2023-02-22 | -$733.00M derived: sum of 3 quarters · filed 2023-02-22 | -$967.00M derived: sum of 4 quarters · filed 2023-02-22 | ||||
| 2020-12-31 | -$350.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | -$417.00M derived: sum of 2 quarters · filed 2023-02-22 | -$651.00M derived: sum of 3 quarters · filed 2023-02-22 | -$778.00M 10-K · filed 2023-02-22 | ||||
| 2020-09-30 | -$67.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$301.00M derived: sum of 2 quarters · filed 2021-11-03 | -$428.00M 10-Q · filed 2021-11-03 | -$263.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-06-30 | -$234.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$361.00M 10-Q · filed 2021-08-05 | -$196.00M derived: sum of 3 quarters · filed 2022-02-23 | $185.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2020-03-31 | -$127.00M 10-Q · filed 2021-05-06 | $38.00M derived: sum of 2 quarters · filed 2022-02-23 | $419.00M derived: sum of 3 quarters · filed 2022-02-23 | $394.00M derived: sum of 4 quarters · filed 2022-02-23 | ||||
| 2019-12-31 | $165.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-23 | $546.00M derived: sum of 2 quarters · filed 2022-02-23 | $521.00M derived: sum of 3 quarters · filed 2022-02-23 | $272.00M 10-K · filed 2022-02-23 | ||||
| 2019-09-30 | $381.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-04 | $356.00M derived: sum of 2 quarters · filed 2020-11-04 | $107.00M 10-Q · filed 2020-11-04 | $199.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-06-30 | -$25.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$274.00M 10-Q · filed 2020-08-06 | -$182.00M derived: sum of 3 quarters · filed 2021-02-25 | $105.00M derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2019-03-31 | -$249.00M 10-Q · filed 2020-05-06 | -$157.00M derived: sum of 2 quarters · filed 2021-02-25 | $130.00M derived: sum of 3 quarters · filed 2021-02-25 | -$1.09B derived: sum of 4 quarters · filed 2021-02-25 | ||||
| 2018-12-31 | $92.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $379.00M derived: sum of 2 quarters · filed 2021-02-25 | -$841.00M derived: sum of 3 quarters · filed 2021-02-25 | -$1.46B 10-K · filed 2021-02-25 | ||||
| 2018-09-30 | $287.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$933.00M derived: sum of 2 quarters · filed 2019-11-05 | -$1.55B 10-Q · filed 2019-11-05 | $3.99B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-06-30 | -$1.22B derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | -$1.84B 10-Q · filed 2019-08-06 | $3.71B derived: sum of 3 quarters · filed 2020-02-25 | $3.59B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2018-03-31 | -$618.00M 10-Q · filed 2019-05-08 | $4.93B derived: sum of 2 quarters · filed 2020-02-25 | $4.81B derived: sum of 3 quarters · filed 2020-02-25 | $4.90B derived: sum of 4 quarters · filed 2020-02-25 | ||||
| 2017-12-31 | $5.54B derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $5.42B derived: sum of 2 quarters · filed 2020-02-25 | $5.52B derived: sum of 3 quarters · filed 2020-02-25 | $5.50B 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | -$120.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$24.00M derived: sum of 2 quarters · filed 2018-11-06 | -$48.00M 10-Q · filed 2018-11-06 | -$67.00M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-06-30 | $96.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $72.00M 10-Q · filed 2018-08-06 | $53.00M derived: sum of 3 quarters · filed 2019-02-26 | $437.00M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2017-03-31 | -$24.00M 10-Q · filed 2018-05-09 | -$43.00M derived: sum of 2 quarters · filed 2019-02-26 | $341.00M derived: sum of 3 quarters · filed 2019-02-26 | $781.00M derived: sum of 4 quarters · filed 2019-02-26 | ||||
| 2016-12-31 | -$19.00M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $365.00M derived: sum of 2 quarters · filed 2019-02-26 | $805.00M derived: sum of 3 quarters · filed 2019-02-26 | $1.01B 10-K · filed 2019-02-26 | ||||
| 2016-09-30 | $384.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $824.00M derived: sum of 2 quarters · filed 2017-11-07 | $1.03B 10-Q · filed 2017-11-07 | $775.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-06-30 | $440.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-07 | $645.00M 10-Q · filed 2017-08-07 | $391.00M derived: sum of 3 quarters · filed 2018-02-27 | $340.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2016-03-31 | $205.00M 10-Q · filed 2017-05-10 | -$49.00M derived: sum of 2 quarters · filed 2018-02-27 | -$100.00M derived: sum of 3 quarters · filed 2018-02-27 | $325.00M derived: sum of 4 quarters · filed 2018-02-27 | ||||
| 2015-12-31 | -$254.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$305.00M derived: sum of 2 quarters · filed 2018-02-27 | $120.00M derived: sum of 3 quarters · filed 2018-02-27 | $269.00M 10-K · filed 2018-02-27 | ||||
| 2015-09-30 | -$51.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-07 | $374.00M derived: sum of 2 quarters · filed 2016-11-07 | $523.00M 10-Q · filed 2016-11-07 | $920.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-06-30 | $425.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $574.00M 10-Q · filed 2016-08-05 | $971.00M derived: sum of 3 quarters · filed 2017-02-27 | $809.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2015-03-31 | $149.00M 10-Q · filed 2016-05-06 | $546.00M derived: sum of 2 quarters · filed 2017-02-27 | $384.00M derived: sum of 3 quarters · filed 2017-02-27 | $441.00M derived: sum of 4 quarters · filed 2017-02-27 | ||||
| 2014-12-31 | $397.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $235.00M derived: sum of 2 quarters · filed 2017-02-27 | $292.00M derived: sum of 3 quarters · filed 2017-02-27 | $533.00M 10-K · filed 2017-02-27 | ||||
| 2014-09-30 | -$162.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$105.00M derived: sum of 2 quarters · filed 2015-11-04 | $136.00M 10-Q · filed 2015-11-04 | $135.67M 10-Q · filed 2014-11-05 | $253.08M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-06-30 | $57.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $298.00M 10-Q · filed 2015-08-05 | $297.67M 10-Q · filed 2014-08-04 | $415.08M derived: sum of 3 quarters · filed 2016-02-24 | $285.68M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2014-03-31 | $241.00M 10-Q · filed 2015-05-08 | $240.97M 10-Q · filed 2014-05-07 | $358.08M derived: sum of 2 quarters · filed 2016-02-24 | $228.68M derived: sum of 3 quarters · filed 2016-02-24 | $258.94M derived: sum of 4 quarters · filed 2016-02-24 | |||
| 2013-12-31 | $117.08M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-24 | -$12.32M derived: sum of 2 quarters · filed 2016-02-24 | $17.94M derived: sum of 3 quarters · filed 2016-02-24 | $30.00M 10-K · filed 2016-02-24 | $30.02M 10-K · filed 2014-02-25 | |||
| 2013-09-30 | -$129.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | -$99.14M derived: sum of 2 quarters · filed 2014-11-05 | -$87.08M 10-Q · filed 2014-11-05 | -$79.41M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-06-30 | $30.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $42.32M 10-Q · filed 2014-08-04 | $49.99M derived: sum of 3 quarters · filed 2015-02-25 | $76.41M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2013-03-31 | $12.06M 10-Q · filed 2014-05-07 | $19.73M derived: sum of 2 quarters · filed 2015-02-25 | $46.15M derived: sum of 3 quarters · filed 2015-02-25 | $43.21M derived: sum of 4 quarters · filed 2015-02-25 | ||||
| 2012-12-31 | $7.67M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-25 | $34.09M derived: sum of 2 quarters · filed 2015-02-25 | $31.15M derived: sum of 3 quarters · filed 2015-02-25 | -$68.00M 10-K · filed 2015-02-25 | -$68.47M 10-K · filed 2013-02-27 | |||
| 2012-09-30 | $26.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-31 | $23.48M derived: sum of 2 quarters · filed 2013-10-31 | -$75.67M 10-Q · filed 2013-10-31 | -$50.08M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-06-30 | -$2.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$102.09M 10-Q · filed 2013-08-01 | -$76.50M derived: sum of 3 quarters · filed 2014-02-25 | -$42.91M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2012-03-31 | -$99.15M 10-Q · filed 2013-05-08 | -$73.56M derived: sum of 2 quarters · filed 2014-02-25 | -$39.97M derived: sum of 3 quarters · filed 2014-02-25 | -$19.85M derived: sum of 4 quarters · filed 2014-02-25 | ||||
| 2011-12-31 | $25.59M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | $59.19M derived: sum of 2 quarters · filed 2014-02-25 | $79.30M derived: sum of 3 quarters · filed 2014-02-25 | $110.77M 10-K · filed 2014-02-25 | ||||
| 2011-09-30 | $33.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $53.70M derived: sum of 2 quarters · filed 2012-11-06 | $85.18M 10-Q · filed 2012-11-06 | $34.94M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-06-30 | $20.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-01 | $51.59M 10-Q · filed 2012-08-01 | $1.35M derived: sum of 3 quarters · filed 2013-02-27 | $30.70M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2011-03-31 | $31.47M 10-Q · filed 2012-05-04 | -$18.76M derived: sum of 2 quarters · filed 2013-02-27 | $10.59M derived: sum of 3 quarters · filed 2013-02-27 | -$4.54M derived: sum of 4 quarters · filed 2013-02-27 | ||||
| 2010-12-31 | -$50.23M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-27 | -$20.89M derived: sum of 2 quarters · filed 2013-02-27 | -$36.01M derived: sum of 3 quarters · filed 2013-02-27 | -$185.73M 10-K · filed 2013-02-27 | ||||
| 2010-09-30 | $29.35M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-04 | $14.22M derived: sum of 2 quarters · filed 2011-11-04 | -$135.50M 10-Q · filed 2011-11-04 | -$87.79M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-06-30 | -$15.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2011-08-05 | -$164.85M 10-Q · filed 2011-08-05 | -$117.13M derived: sum of 3 quarters · filed 2012-02-23 | -$48.57M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2010-03-31 | -$149.72M 10-Q · filed 2011-05-09 | -$102.01M derived: sum of 2 quarters · filed 2012-02-23 | -$33.45M derived: sum of 3 quarters · filed 2012-02-23 | -$33.99M derived: sum of 4 quarters · filed 2012-02-23 | ||||
| 2009-12-31 | $47.71M derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-23 | $116.27M derived: sum of 2 quarters · filed 2012-02-23 | $115.73M derived: sum of 3 quarters · filed 2012-02-23 | $166.33M 10-K · filed 2012-02-23 | ||||
| 2009-09-30 | $68.56M derived: 10-Q 9 month − 10-Q 6 month · filed 2010-11-08 | $68.02M derived: sum of 2 quarters · filed 2010-11-08 | $118.62M 10-Q · filed 2010-11-08 | $85.85M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-06-30 | -$545.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2010-08-09 | $50.06M 10-Q · filed 2010-08-09 | $17.29M derived: sum of 3 quarters · filed 2011-02-28 | $2.59M derived: sum of 4 quarters · filed 2011-02-28 | ||||
| 2009-03-31 | $50.60M 10-Q · filed 2010-05-10 | $17.83M derived: sum of 2 quarters · filed 2011-02-28 | $3.14M derived: sum of 3 quarters · filed 2011-02-28 | |||||
| 2008-12-31 | -$32.77M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-28 | -$47.47M derived: sum of 2 quarters · filed 2011-02-28 | -$23.89M 10-K · filed 2011-02-28 | |||||
| 2008-09-30 | -$14.70M derived: 10-Q 9 month − 10-Q 6 month · filed 2009-11-05 | $8.88M 10-Q · filed 2009-11-05 | ||||||
| 2008-06-30 | $23.58M 10-Q · filed 2009-08-05 | |||||||
| 2007-12-31 | $76.99M 10-K · filed 2010-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMGEN INC (AMGN) | United States | $219.567B | 22.39 |
| Moderna, Inc. (MRNA) | United States | $77.819B | -8.86 |
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| BIOGEN INC. (BIIB) | United States | $33.427B | 19.60 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |